The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
AdventHealth Launches Research Study to Evaluate an Evidence-based Intervention Designed to Address Physician Burnout
-
AdventHealth for Children Recruiting Patients with Fabry Disease for Phase III PERIDOT Clinical Trial Evaluating a Potential New Treatment Option
-
New State-of-the-Art Cellular Therapy Facility Opening at AdventHealth Orlando
-
Creed Guitarist Mark Tremonti and AdventHealth for Children Pediatrician Discuss the Southeast’s First Lifespan Down Syndrome Clinic
-
A Day in the Life of Osceola County’s Only ER Specifically for Kids
-
New AdventHealth for Children Program will be 1st in Southeast to Care for Kids and Adults with Down Syndrome
-
Aquadex Ultrafiltration Device Provides New Hemodialysis Option for Neonates Experiencing Renal Failure
-
AdventHealth physicians explain Post-COVID Clinic model and first year research findings during American Hospital Association podcast